Emin KANSU, Ceyhun BOZKURT, Nazmiye YÜKSEK, Süreyya BOZKURT, Nilüfer ARDA, Gürses ŞAHİN, Dicle GÜÇ, Ayşe Ulya ERTEM

P16 and p27 tumor suppressor gene methylation status in childhood Wilms tumor cases

To analyze the methylation status of the promoter regions of p16 and p27 genes in Wilms tumor patients. These tumor suppressor genes are associated with 2 main pathways regulating the G1/S transition of the cell cycle. Materials and methods: Sixteen patients with Wilms tumor were included in the study. The methylation status of CpG islands in the p16 and p27 genes was analyzed by the polymerase chain reaction (PCR) technique in the tumor tissue samples obtained from all patients. Five tissue samples of normal kidney were obtained from pathology department archives. Results: P16 gene promoter methylation was detected in 2 of 16 (12.5%) patients, one of which was heterozygous and the other homozygous. P27 gene promoter methylation was also found in 2 of 16 (12.5%) patients, one of which was heterozygous and the other homozygous. No methylation status was observed in normal kidney tissues. Conclusion: Our results showed that the incidence of CpG island promoter region methylation of the p16 and p27 tumor suppressor genes in Wilms tumor was low. However, larger series are needed to determine the prognostic value of DNA methylation of p16 and p27 in Wilms tumor patients.

Anahtar Kelimeler:

Key words: Wilms tumor, p16 gene, p27 gene, methylation, epigenetic

P16 and p27 tumor suppressor gene methylation status in childhood Wilms tumor cases

Keywords:

Key words: Wilms tumor, p16 gene, p27 gene, methylation, epigenetic,

PDF

___

Feinberg AP. Th e Epigenetic of cancer etiology. Semin Cancer Biol 2004; 14: 427-32. 2. Singal R, Ginder GD. DNA methylation. Blood 1999; 93: 4059- 70.
Tsellou E, Troungos C, Moschovi MP, Athanasiadou- Piperopoulou F, Polychronopoulou S, Kosmidis H et al. Hypermethylation of CpG island in the promoter region of the p15INK4b gene in childhood acute leukemia. Eur J Cancer. 2005; 41: 584-9. 4. Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O’Keefe CL, Matera AG et al. Growth Suppressor by p18, p16 INK4/MTS1 and p14 INK4B/MTS2 related CDK6 inhibitor correlates wild- type pRb function. Genes Dev 1994; 15: 2939-52.
Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 1995; 6: 387-400. 6. Lowe SW, Sherr CJ. Tumor suppression by INK4a-Arf: progress and puzzles. Curr Opin Genet Dev. 2003; 13: 77-83.
Auerkari EI. Methylation of tumor suppressor genes p16 (INK4a), p27 (Kip1) and E-cadherin in carcinogenesis. Oral Oncol 2006; 42: 5-13.
Baylin SB, Chen WY. Aberrant gene silencing in tumor progression: implications for control of cancer. Cold Spring Harb Symp Quant Biol 2005; 70: 427-33. 9. Matsuda Y. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma. World Gastroenterol 2008; 14: 1734- 40.
Nakamuro M, Sakaki T, Hashimoto H, Nakase H, Ishida E, Shimada K et al. Frequent alterations of the p14 (ARF) and p16 (INK4a) genes in primary central nervous system lymphomas. Cancer Res 2001; 61: 6335-6339.
Herman GJ, Graff RJ, Myohanen S, Nelkin BD, Baylin SB. Methylation specifi c PCR: a novel PCR assay for methylation status of CPG islands. Proc Natl Acad Sci 1996; 93: 9821-6.
Kanai Y. Alteration of DNA methylation and clinicopathological diversity of human cancers. Pathology International 2008; 58: 544-58.
Gronbaek K, Hother C, Jones PA. Epigenetic changes in cancer. APMIS 2007; 115: 1039-1059.
Goldstein M, Meller I, Orr-Urtreger A. FGFR 1 over-expression in primary rhabdomyosarcoma tumors is associated with hypomethylation of a 5’ CpG island and abnormal expression of the AKT1, NOG, and BMP4 genes. Genes Chromosomes Cancer 2007; 46: 1028-38
Watanabe M, Ogawa Y, Itoh K, Koiwa T, Kadin ME, Watanabe T et al. Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma. Lab Invest 2008; 88: 48-57.
Nishyama R, Qi L, Lacey M, Ehrlich M. Both hypomethylation and hypermethylation in a 0.2-kb region of a DNA repeat in cancer. Mol Cancer Res 2005; 3: 617-26.
Erlich M, Jiang G, Fiala E, Dome JS, Yu MC, Long TI et al. Hypomethylation and hypermethylation of DNA in Wilms tumor. Oncogene 2002; 21: 6694-702.
Sanchez-Beato M, Saez AI, Navas IC, Algara P, Sol Mateo M, Villuendas R et al. Overall survival in aggressive B-cell lymphoma is dependent on the accumulation of alterations in p53, p16, and p27. Am J Pathol 2001; 159: 205-13.
Chim S, Fung TK, Wong KF, Lau JS, Law M, Liang R et al. Methylation of INK4 and CIP/KIP families of Cyclin- dependent kinases inhibitor in chronic lymphocytic leukemia in Chinese patients. J Clin Pathol 2006; 59: 921-926.
Nakayama G, Hibi K, Kodera Y, Koike M, Fujiwara M, Nakao A et al. P16 methylation in serum as a potential marker for the malignancy of colorectal carcinoma. Anticancer Res 2007; 27: 3367-70.
Kawauchi S, Liu XP, Kawasaki K, Hirakawa T, Amada S, Furuya T et al. Signifi cance of beta catenin and PRB pathways components in malignant ovarian germ cell tumors: INK4A promoter CpG island methylation is associated with cell proliferation. J Pathol 2004; 204: 268-76.
Qian X, Jin L, Kulig E, Lloyd RV. DNA methylation regulates p27 kip1 expression in rodent pituitary cell lines. Am J Pathol 1998; 153: 1475-83.
Bardeesy N, Falkoff D, Petruzzi MJ, Nowak N, Zabel B, Adam M et al. Anaplastic Wilms’ tumor, a subtype displaying poor prognosis, harbors p53 gene mutations. Nat Genet 1994; 7: 91-7.
Vidaurreta M, Maestro ML, Sanz-Casla MT, Maestro C, Rafael S, Veganzones S et al. Inactivation of p16 by CpG hypermethylation in renal cell carcinoma. Urol Oncol. 2008; 26: 239-45.
Arcellana-Panlilio MY, Egeler RM, Ujack E, Pinto A, Demetrick DJ, Robbins SM et al. Decreased expression of the INK4 family of Cyclin-dependent kinases inhibitors in Wilms tumor. Genes Chromosomes Cancer 2000; 29: 63-9.
Faussillon M, Monnier L, Junien C, Jeanpierre C. Frequent over expression of Cyclin D2/Cyclin-dependent kinases 4 in Wilms’ tumor. Cancer Lett 2005; 221: 67–75.
Morris MR, Hesson LB, Wagner KJ, Morgan NV, Astuti D, Lees RD et al. Multigene methylation analysis of Wilms’ tumor and adult renal cell carcinoma. Oncogene 2003; 22: 6794-801.
Brakensiek K, Langer F, Kreipe H, Lehmann U. Absence of p21 (CIP1), p27 (KIP1) and P57 (KIP2) methylation in MDS and AML. Leuk Res 2005; 29: 1357-60.
Chim CS, Wong ASY, Kwong YL. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias. Am J Hematol 2005; 80: 282-7.
Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K et al. PKB/Akt phosphoraletes p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 2002; 8: 1153-60.